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Introduction: There is a sex discrepancy in cardiovascular physiology. In this study, 
we aimed to investigate the effect of female reproductive factors on coronary artery 
disease (CAD) beyond the known CAD risk factors. 
Methods: In a case-control study, women referred to Tehran Heart Center for 
coronary artery angiography from 2012 to 2014 were enrolled. Of these, 80 
premenopausal and 100 postmenopausal females with CAD in angiography were 
randomly selected as cases and 80 premenopausal and 100 postmenopausal females 
without CAD in angiography were selected as controls. A questionnaire including 
reproductive history and known CAD risk factors was filled for every subject. Analysis 
was performed separately for pre and postmenopausal women and a final adjustment 
for coronary artery disease risk factors was done. 
Results: Among reproductive factors, oligomenorrhea (OR= 6.72) was a significant 
risk factor for CAD in premenopausal women and history of oral contraceptive (OCP) 
use had a protective effect on CAD in pre and postmenopausal woman (OR= 0.24 and 
0.20, respectively). 
Conclusions: Since oligomenorrhea has a strong association with insulin resistance 
and diabetes, a conventional risk factor of CAD, women with oligomenorrhea should 
be treated not only for cyclic irregularity but also for prevention of CAD. 
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INTRODUCTION
Cardiovascular disease is the most common cause of 
death-worldwide. Incidence of coronary artery disease 
(CAD) in premenopausal women is lower than men at 
the same age. There are a lot of evidence about sex 
differences in the molecular and cellular physiology of 
the heart and blood vessels [1]. Female hormones, 
mainly estrogens, modify blood lipids and blood 
pressure and the levels vary during pregnancy [2]. 
Moreover, pregnancy is a state that leads to insulin 
resistance, undesirable lipid profile and elevated 
coagulation factors [3]. It has been reported that some 
of these changes continue several years after pregnancy 
[3]. So, number of pregnancies and age at first 
pregnancy may affect cardiovascular health status as well 
as hormonal level. Menstrual cycle irregularity has been 
shown to be a sign of insulin resistance [4]. Moreover, 
polycystic ovarian syndrome (PCOS), the most 
common cause of oligomenorrhea, has strong 
association with conventional CAD risk factors such as 
insulin resistance, diabetes, hypertension and 
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dyslipidemia [5]. In addition to pregnancy, 
reproductive history and menstrual cycle irregularity, 
hormonal medicines such as oral contraceptives (OCP) 
probably have some effects on cardiovascular status 
because of alteration in hormonal level in circulation. In 
this study, we attempted to investigate the effect of 
reproductive and hormonal factors on coronary artery 
disease beyond the known CAD risk factors. 
METHODS 
In this case-control study, women who referred to 
Tehran Heart Center for coronary artery angiography 
from 2012 to 2014 were included. Women with prior 
history of hysterectomy were excluded. Of these, 80 
premenopausal and 100 postmenopausal females with 
CAD in angiography, were randomly selected as cases 
and 80 premenopausal and 100 postmenopausal 
females without CAD in angiography were selected as 
controls. Coronary artery disease was defined as luminal 
stenosis ≥ 50% in at least one pericardial coronary artery. 
A questionnaire including demographic data, 
reproductive history and known CAD risk factors, was 
filled for all participants. Demographic data involved 
age, education level, job status and body mass index 
(BMI). Reproductive factors were included the number 
of pregnancies, number of children, number of 
abortions, age at first pregnancy, age at menarche, 
oligomenorrhea, menopausal status, age of menopause, 
type of menopause, OCP use, duration of OCP use, 
hormonal replacement therapy (HRT), and duration of 
HRT. 
Traditional CAD risk factors, including diabetes (DM), 
hypertension (HTN), hyperlipidemia (HLP), cigarette 
smoking (CS) and family history of CAD were also 
evaluated. It is certified that all ethical considerations, 
i.e., applicable institutional and governmental 
regulations concerning the ethical use of human 
volunteers were followed during this research. Informed 
written consent was obtained from all participants and 
the Ethical Committee of Tehran University of Medical 
Sciences approved this study. The study protocol 
conforms to the ethical guidelines of the 2008 
Declaration of Helsinki [6].Our gathered data were 
confidential and no extra cost was constrained on our 
participants. Analysis was carried out separately for pre 
and postmenopausal women. Independent samples t- 
test was used for comparison of numerical variables as 
well as Pearson chi-square and Fisher’s exact test for 
categorical data. Final adjustment for confounding 
factors including conventional CAD risk factors (HTN, 
diabetes, FH, age) was carried out by multiple logistic 
regression models. The statistical significance level was 
set at a two-tailed type I error of 0.05. All statistical 
analyses were performed using SPSS version 15.  
RESULTS 
As is shown in Table 1 and 2, univariate analysis in 
premenopausal women determined that increasing age 
and number of children besides decreasing age at first 
pregnancy among the numerical data as well as 
oligomenorrhea, being house-wife, low education, 
having no partner, DM, HTN and family history of CAD 
among categorical data were associated with CAD. 
However after adjusting all variables for CAD, only 
three characteristics remained significant (Table 3); 
DM with odds ratio (OR) of 6.32, HTN with OR of 9.01 
and oligomenorrhea with OR of 6.72. 
Among numerical variables in postmenopausal women 
in univariate analysis, increasing age and number of 
children besides decreasing age at first pregnancy, age of 
menopause and duration of OCP use were associated 
with CAD (Table 1). There was also a relation between 
CAD and oligomenorrhea, being house-wife, having no 
history of OCP use, DM and family history of CAD 
among categorical variables in postmenopausal women 
(Table 2). After adjusting all variables for CAD, the 
subsequent items were significantly correlated (Table 
4): increasing age with OR of 1.36, DM with OR of 5.18 
and family history of CAD with OR of 8.33. 
Also, history of OCP use with OR of 0.24 and 0.20, 
respectively in pre and postmenopausal women was a 
protective factor against CAD. In addition, increase in 
age of menopause with OR of 0.80 had protective effect 
on CAD (Table 4). 
 
Table 1: Demographic Numerical Variables of Premenopausal and Postmenopausal Women 
 Premenopausal women Postmenopausal women 
Variable 
CAD, n=80, 
mean ± SD 
No CAD, n=80, 
mean ± SD 
P value 
CAD, n=100, , 
mean ± SD 
No CAD, n=100, 
mean ± SD 
P value 
Age (years) 46.01 ± 6.02 43.6 ± 6.6 0.02* 61.6 ± 5.1 55.08 ± 4.9 <0.001* 
Number of pregnancies 3.6 ± 2.6 3.1 ± 1.09 0.10 6.01 ± 2.4 5.4 ± 2.5 0.09 
Number of children 2.9 ± 1.9 2.4 ± 1.02 0.04* 5.08 ± 2.2 3.9 ± 1.6 <0.001* 
Number of abortions 0.6 ± 0.4 0.7 ± 0.7 0.70 1 ± 0.2 1.08 ± 0.4 0.60 
Age at first pregnancy 
(years) 
19.2 ± 4.5 22.3 ± 6.6 0.001* 17.6 ± 2.09 18.7 ± 4.05 0.01* 
Age at menarche (years) 12.8 ± 1.1 12.4 ± 2.2 0.21 12.9 ± 1.1 12.8 ± 1.3 0.30 
Duration of OCP use 
(months) 
55.6 ± 38.7 49 ± 36.3 0.50 26.6 ± 8.6 37.08 ± 12 0.002* 
BMI (kg/m2) 29.7 ± 7.1 28.2 ± 2.8 0.08 28.8 ± 4.9 30.04 ± 6.1 0.10 
Menopausal age (years) - - - 45.4 ± 4.8 50.9 ± 5.3 <0.001 
*P<0.05 significant 
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Table 2: Demographic Categorical Variables of Premenopausal and Postmenopausal Women 
Variable Premenopausal women Postmenopausal women 
 
CAD, n=80, 
mean  ±  SD 
No CAD, 
n=80, mean  














Oligomenorrhea 28(35%) 4(5%) <0.001* 
10.2 (3.3-
30.9) 
20(20%) 5(5%) 0.001* 4.7 (1.7-13.2) 
OCP use 21(26.3%) 23(28.8%) 0.70 - 17(17%) 75(75%) <0.001* 
0.06 (0.03-
0.1) 
House wife 59(73.8%) 25(31.3%) <0.001* 6.1 (3.1-12.2) 89(89%) 74(74%) <0.001* 2.8 (1.3-6.1) 
Education 
(≤diploma) 
40(50%) 20(25%) 0.001* 3 (1.5-5.8) 85(85%) 80(80%) 0.30 - 
Marital status 
(unmarried) 
8(10%) 1(1.3%) 0.03* 8.7 (1.07-7) 1(1%) 5(5%) 0.20 - 
DM 44(55%) 12(15%) <0.001* 6.9 (3.2-14.7) 65(65%) 40(40%) <0.001* 2.7 (1.5-4.9) 
HTN 48(60%) 16(20%) <0.001* 6 (2.9-12.1) 70(70%) 60(60%) 0.10 - 
HLP 52(65%) 44(55%) 0.10 - 80(80%) 75(75%) 0.30 - 
C/S 4(5%) 4(5%) 10 - 5(5%) 1(1%) 0.20 - 
FH 52(65%) 28(35%) <.001* 3.4 (1.8-6.6) 60(60%) 20(20%) <.001* 6 (3.1-11.2) 
HRT - - -  5(5.9%) 10(10.5%) 0.20 - 
Surgical 
menopause 
- - -  15(15%) 25(25%) 0.07 - 




Table 3: Adjusted Odds Ratio in Premenopausal Women 
Variable P value Adjusted OR (95%CI) 
Diabetes <0.001 6.32 (2.68-14.89) 
Hypertension <0.001 9.01 (3.01-26.93) 
Oligomenorrhea 0.002 6.72 (1.96-23.03) 
OCP  0.024 0.24 (0.07-0.82) 
 
Table 4: Adjusted Odds ratio in Postmenopausal Women 
Variable P value Adjusted OR (95%CI) 
Age <0.001 1.36 (1.21-1.53) 
Menopausal Age <0.001 0.80 (0.71-0.89) 
OCP  0.002 0.20 (0.07-0.55) 
Diabetes 0.002 5.18 (1.82-14.72) 
Family history of CAD <0.001 8.33 (2.96-23.45) 
DISCUSSION
This study shows that diabetes is the most important 
coronary artery disease risk factor in women (adjusted 
OR in premenopausal age = 6.32, adjusted in 
postmenopausal age = 5.18) that is consistent with 
results of The Women's Ischemia Syndrome Evaluation 
(WISE) study in 2003 [7]. It has been approved that 
diabetic women have more menstrual irregularity, lower 
blood estrogen levels, and higher androgen levels than 
non-diabetic [7]. Moreover, it has been established that 
hypoestrogenemia in female is accompanied by a 
diminution of normal vasodilatation and even 
vasoconstriction in response to stress [7]. It seems that 
one of the most important harmful effects of diabetes on 
female that leads to CAD comes from the ability of 
diabetes to change hormonal level. So, diabetes -not 
only influences on cardiovascular status with a direct 
effect on vascular system, but also in an indirect way by 
changing hormonal levels. That is why diabetes is the 
most significant risk factor for CAD in women. Our 
study results after adjustment for confounders did not 
confirmed age at first birth as a risk factor for CAD. This 
finding is similar to findings of Colditz et al. [8] study 
while contrasts with the results of Kharazmi et al. [9] 
and Cooper et al. [10] studies, which confirmed 
increased risk in women with lower and higher maternal 
age at first birth, respectively. However, Hardy et al.'s 
study showed that lower age at first birth is associated 
with higher CAD risk factors in both genders [11]. The 
main advantage of Hardy et al.'s study over other studies 
was prospective data collection during reproductive 
years instead of recalling in the later life [11]. In another 
recent study by Pirkle et al. in Canada, no significant 
association was found between low maternal age at first 
birth and CAD [12]. 
In our study, after adjustment of results for confounding 
factors there was no significant association between 
number of children and CAD as it was observed in 
earliest Hardy et al.'s study [13]. Both Hardy et al.'s 
studies concluded that any association between CAD 
risk factors and number of children or parental age at 
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first birth is a result of family lifestyle and behaviors 
rather than biological effect of pregnancy in women [11, 
13]. The association between parity and CAD was also 
confirmed by later studies by Parikh et al. and Pirkle et 
al. [12, 14] while Jacobsen et al. did not find any 
association between parity and total, ischemic heart 
disease or stroke mortality [15]. Oligomenorrhea with 
odds ratio of 6.72 was another reproductive risk factor 
associated with CAD in premenopausal but not 
postmenopausal women in our study. Menstrual 
irregularity is one of the predictors of future diabetes and 
then coronary artery disease [4]. To the best of our 
knowledge, Poly cystic ovarian syndrome (PCOS) is the 
most common cause of menstrual irregularity, 
specifically oligomenorrhea is associated with metabolic 
disorders and subsequent CAD. Thus, this correlation 
between oligomenorrhea and CAD is rational. A study 
by Wang et al. in 2011 showed a non-significant 
increased risk of CAD in women with menstrual 
irregularity which after adjustment for BMI changed to 
nonsignificant [16] which in our study remained 
significant (Table 3). 
Age at menopause was another reproductive factor 
significantly associated with CAD in postmenopausal 
women in our study. Similar to ours, He et al.'s study 
showed significant association between age at 
menopause and CAD in rural Chinese women with odds 
ratio of 1.02 which is higher than our study (0.80) 
[17].In fact in our study, higher age at menopause has 
protective effect on CAD( Table 4). Present study did 
not find any significant association between age at 
menarche and CAD in women while CVD mortality was 
associated inversely with age at menarche in non-
smoker women in China [18]. Wu et al.'s study found 
that younger age at menarche and menopause are 
associated with higher risk of total mortality and 
mortality from stroke, respectively [19]. 
Canoy et al.'s cohort showed significantly increased risk 
of CAD both in early and late ages at menarche [20]. 
Another study in China also found a significant 
association between higher ages at menarche and 
menopause and lower risk of CVD [21]. In this study, 
there was an adverse relation between OCP use and 
CAD in pre and postmenopausal women and OCP was 
a protective factor against CAD. This has been 
confirmed by other studies. Kaplan et al [22] have 
demonstrated that contraceptive hormone treatment 
inhibits the acceleration of atherosclerosis in female 
monkeys. BairyMerz et al. [23] also reported that past 
oral contraceptive use was associated with an 
approximately 2.5 lower CAD severity and Stampfer  et 
al. [24] verified a lower RR (0.8) in OCP users for CAD. 
Greater flow mediated dilation in OCP users may be 
cause of such protection against CAD [25].  
CONCLUSIONS 
In animal studies it has been found that OCP blocked 
the neuroendocrine stress response in primate [24]. 
This capability protects cardiovascular system from the 
adverse effect of stressors. In addition to this benefit, 
OCP correct menstrual irregularity that may be leads to 
diabetes and CAD. Therefore, OCP could be an 
appropriate choice for treatment of menstrual 
irregularity. The main limitation of our study is recall 
bias that is probable in both groups of women and it 
should be considered in interpretation of results. 
Diabetes is the most important risk factor for CAD in 
both pre and postmenopausal women, so that female 
with diabetes must be strictly under treatment. Among 
reproductive factors, after adjusting all known CAD risk 
factors and reproductive factors for CAD, only 
oligomenorrhea in premenopausal women and age at 
menopause in postmenopausal women were associated 
with CAD. Since, oligomenorrhea could lead to diabetes 
and had subsequent CAD risk, all women with cyclic 
irregularity should be treated to prevent from later 
CAD. Also, OCP has a protective effect on 
cardiovascular disease both in pre and postmenopausal 
women, therefore could be an appropriate choice for 
treatment of these patients. 
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